| Literature DB >> 31652604 |
Zarko Barjaktarovic1,2, Juliane Merl-Pham3, Ignacia Braga-Tanaka4, Satoshi Tanaka5, Stefanie M Hauck6, Anna Saran7, Mariateresa Mancuso8, Michael J Atkinson9,10, Soile Tapio11, Omid Azimzadeh12.
Abstract
Chronic exposure to low-dose ionizing radiation is associated with an increased risk of cardiovascular disease. Alteration in energy metabolism has been suggested to contribute to radiation-induced heart pathology, mitochondrial dysfunction being a hallmark of this disease. The goal of this study was to investigate the regulatory role of acetylation in heart mitochondria in the long-term response to chronic radiation. ApoE-deficient C57Bl/6J mice were exposed to low-dose-rate (20 mGy/day) gamma radiation for 300 days, resulting in a cumulative total body dose of 6.0 Gy. Heart mitochondria were isolated and analyzed using quantitative proteomics. Radiation-induced proteome and acetylome alterations were further validated using immunoblotting, enzyme activity assays, and ELISA. In total, 71 proteins showed peptides with a changed acetylation status following irradiation. The great majority (94%) of the hyperacetylated proteins were involved in the TCA cycle, fatty acid oxidation, oxidative stress response and sirtuin pathway. The elevated acetylation patterns coincided with reduced activity of mitochondrial sirtuins, increased the level of Acetyl-CoA, and were accompanied by inactivation of major cardiac metabolic regulators PGC-1 alpha and PPAR alpha. These observations suggest that the changes in mitochondrial acetylation after irradiation is associated with impairment of heart metabolism. We propose a novel mechanism involved in the development of late cardiac damage following chronic irradiation.Entities:
Keywords: PPAR alpha; TBI; acetylome; cardiovascular disease; chronic exposure; heart; ionising radiation; mitochondria; proteomics; sirtuins
Mesh:
Substances:
Year: 2019 PMID: 31652604 PMCID: PMC6829468 DOI: 10.3390/ijms20205239
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Proteome analysis of mitochondrial proteins in the irradiated heart. (A) Principal component analysis (PCA) based on all proteomic features. (B) Graphical representation of quantitative proteomics data of cardiac mitochondria after chronically exposure to accumulated doses of 6 Gy. Proteins are ranked in a volcano plot according to the −log10 of their statistical p-value (y-axis) and log2 fold change (x-axis). The yellow points represent the significantly more abundant proteins in cardiac mitochondria after irradiation, the blue points represent the significantly less abundant proteins. (C) The most significant canonical pathways altered by irradiation. The analyses were generated through the use of IPA (QIAGEN Inc., https://www.qiagenbio-informatics.com/products/ingenuity-pathway-analysis). Bars indicate canonical pathways and the y-axis displays the −(log p) enrichment significance. Taller bars are more significant than shorter bars.
Figure 2Protein-protein interaction analysis of acetylated proteins changed following total body irradiation. Principal component analysis (PCA) based on all acetylated peptides features (A). Heat map showing higher abundance of acetylated peptides (in yellow) in irradiated samples compared to the controls (B). Protein–protein interactions are analyzed by the STRING software tool (http://string-db.org) indicating the most affected protein clusters (C).
List of significantly changed acetylated mitochondrial proteins following irradiation (p < 0.05). The number of acetylated peptides, Gene Ontology (GO) description and GO Accession are shown for each acetylated protein.
| No. | ID | Description | No. Of Hyperacetylated Peptides | No. Of Hypoacetylated Peptides | GO Description | GO Accession |
|---|---|---|---|---|---|---|
| 1 | ACAA2 | 3-ketoacyl-CoA thiolase | 2 | 0 | FAO | GO:0006635 |
| 2 | ACADL | Long-chain specific acyl-CoA dehydrogenase | 2 | 0 | FAO | GO:0006635 |
| 3 | ACADM | Medium-chain specific acyl-CoA dehydrogenase | 1 | 0 | FAO | GO:0006635 |
| 4 | ACAT1 | Acetyl-CoA acetyltransferase | 1 | 0 | FAO | GO:0006635 |
| 5 | ACO2 | Aconitate hydratase | 6 | 1 | TCA metabolic process | GO:0072350 |
| 6 | ACOT13 | Acyl-coenzyme A thioesterase 13 | 4 | 0 | acyl-CoA hydrolase activity | GO:0047617 |
| 7 | ACOT5 | Acyl-coenzyme A thioesterase 5 | 1 | 0 | acyl-CoA hydrolase activity | GO:0047617 |
| 8 | ALDH4A1 | Delta-1-pyrroline-5-carboxylate dehydrogenase | 1 | 0 | TCA metabolic process | GO:0072350 |
| 9 | ATP5A1 | ATP synthase subunit alpha | 1 | 0 | ATP metabolic process | GO:0046034 |
| 10 | ATP5B | ATP synthase subunit beta | 2 | 0 | ATP metabolic process | GO:0046034 |
| 11 | ATP5F1 | ATP synthase F(0) complex subunit B1 | 3 | 0 | ATP metabolic process | GO:0046034 |
| 12 | ATP5H | ATP synthase subunit d | 9 | 0 | ATP metabolic process | GO:0046034 |
| 13 | ATP5L | ATP synthase subunit g | 2 | 0 | ATP metabolic process | GO:0046034 |
| 14 | ATP5O | ATP synthase subunit O | 1 | 0 | ATP metabolic process | GO:0046034 |
| 15 | AUH | Methylglutaconyl-CoA hydratase | 1 | 0 | FAO | GO:0006635 |
| 16 | CBLB | E3 ubiquitin-protein ligase | 1 | 0 | ubiquitin protein ligase binding | GO:0031625 |
| 17 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1 | 2 | 0 | ATP metabolic process | GO:0046034 |
| 18 | CUX1 | Homeobox protein cut-like 1 | 1 | 0 | DNA binding | GO:0003677 |
| 19 | CWC27 | Peptidyl-prolyl cis-trans isomerase | 1 | 0 | protein folding | GO:0006457 |
| 20 | CYCS | Cytochrome c | 1 | 0 | ATP metabolic process | GO:0046034 |
| 21 | DECR1 | 2-4-dienoyl-CoA reductase | 1 | 0 | FAO | GO:0006635 |
| 22 | DLD | Dihydrolipoyl dehydrogenase | 3 | 1 | ATP metabolic process | GO:0046034 |
| 23 | DLST | Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex | 1 | 0 | TCA metabolic process | GO:0072350 |
| 24 | ECHS1 | Enoyl-CoA hydratase | 1 | 0 | FAO | GO:0006635 |
| 25 | ETFA | Electron transfer flavoprotein subunit alpha | 3 | 1 | FAO | GO:0006635 |
| 26 | ETFB | Electron transfer flavoprotein subunit beta | 1 | 0 | FAO | GO:0006635 |
| 27 | FAM187A | Ig-like V-type domain-containing protein | 1 | 0 | enzyme binding | GO:0019899 |
| 28 | FGD6 | RhoGEF and PH domain-containing protein 6 | 1 | 0 | regulation of GTPase activity | GO:0043087 |
| 29 | FH | Fumarate hydratase | 5 | 0 | TCA metabolic process | GO:0072350 |
| 30 | GBAS | Protein NipSnap homolog 2 | 1 | 0 | ATP metabolic process | GO:0046034 |
| 31 | GLUD1 | Glutamate dehydrogenase 1 | 1 | 0 | TCA metabolic process | GO:0072350 |
| 32 | GOT2 | Aspartate aminotransferase | 3 | 1 | amino acid binding | GO:0016597 |
| 33 | HADH | Hydroxyacyl-coenzyme A dehydrogenase | 1 | 0 | FAO | GO:0006635 |
| 34 | HADHA | Trifunctional enzyme subunit alpha | 7 | 0 | FAO | GO:0006635 |
| 35 | HIST1H1C | Histone H1 | 1 | 0 | DNA binding | GO:0003677 |
| 36 | HIST1H1E | Histone H1 | 1 | 0 | ATP binding | GO:0005524 |
| 37 | HMGCL | Hydroxymethylglutaryl-CoA lyase | 1 | 0 | fatty-acyl-CoA binding | GO:0000062 |
| 38 | HSPA9 | Stress-70 protein | 1 | 0 | unfolded protein binding | GO:0051082 |
| 39 | HSPD1 | 60 kDa heat shock protein | 1 | 0 | unfolded protein binding | GO:0051082 |
| 40 | IDH2 | Isocitrate dehydrogenase [NADP] | 12 | 0 | TCA metabolic process | GO:0072350 |
| 41 | IDH3A | Isocitrate dehydrogenase [NADP] | 0 | 1 | TCA metabolic process | GO:0072350 |
| 42 | LRRC40 | Leucine-rich repeat-containing protein 40 | 1 | 0 | cellular process | GO:0009987 |
| 43 | MDH1B | Putative malate dehydrogenase 1B | 1 | 0 | TCA metabolic process | GO:0072350 |
| 44 | MDH2 | Malate dehydrogenase | 6 | 0 | TCA metabolic process | GO:0072350 |
| 45 | MMEL1 | Membrane metallo-endopeptidase-like 1 | 1 | 0 | endopeptidase activity | GO:0004175 |
| 46 | MRGPRA1 | Mas-related G-protein coupled receptor member A1 | 0 | 1 | G protein-coupled receptor activity | GO:0004930 |
| 47 | MYH6 | Myosin-6 | 2 | 1 | actin-dependent ATPase activity | GO:0030898 |
| 48 | NDUFA2 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 | 1 | 0 | NADH dehydrogenase (ubiquinone) activity | GO:0008137 |
| 49 | NDUFAB1 | Acyl carrier protein | 0 | 1 | acyl binding | GO:0000035 |
| 50 | NDUFB3 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 | 1 | 0 | NADH dehydrogenase (ubiquinone) activity | GO:0008137 |
| 51 | NDUFS1 | NADH-ubiquinone oxidoreductase 75 kDa subunit | 2 | 0 | NADH dehydrogenase (ubiquinone) activity | GO:0008137 |
| 52 | NDUFV2 | NADH dehydrogenase [ubiquinone] flavoprotein 2 | 1 | 0 | NADH dehydrogenase (ubiquinone) activity | GO:0008137 |
| 53 | NIT2 | Omega-amidase NIT2 | 1 | 0 | omega-amidase activity | GO:0050152 |
| 54 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1 | 1 | 0 | 3-oxoacid CoA-transferase activity | GO:0008260 |
| 55 | PAPOLB | Poly(A) polymerase beta | 1 | 0 | RNA polymerase binding | GO:0070063 |
| 56 | PDHA1 | Pyruvate dehydrogenase E1 component subunit alpha | 1 | 0 | TCA metabolic process | GO:0072350 |
| 57 | PRDX5 | Peroxiredoxin-5 | 2 | 0 | response to oxygen radical | GO:0000305 |
| 58 | PROSC | Proline synthase co-transcribed bacterial homolog protein | 1 | 0 | pyridoxal phosphate binding | GO:0030170 |
| 59 | RPIA | Ribose-5-phosphate isomerase | 1 | 0 | carbohydrate binding | GO:0030246 |
| 60 | SDHA | Succinate dehydrogenase [ubiquinone] flavoprotein subunit | 4 | 0 | TCA metabolic process | GO:0072350 |
| 61 | SLC25A3 | Phosphate carrier protein | 1 | 0 | phosphate transmembrane transporter | GO:0005315 |
| 62 | SLC25A4 | ADP/ATP translocase 1 | 2 | 1 | ATP:ADP antiporter activity | GO:0005471 |
| 63 | SLC25A5 | ADP/ATP translocase 2 | 1 | 0 | ATP:ADP antiporter activity | GO:0005471 |
| 64 | SOD2 | Superoxide dismutase [Mn] | 1 | 0 | response to oxygen radical | GO:0000305 |
| 65 | SUCLA2 | Succinate--CoA ligase [ADP-forming] subunit beta | 1 | 0 | TCA metabolic process | GO:0072350 |
| 66 | SUCLG1 | Succinate--CoA ligase [ADP/GDP-forming] subunit alpha | 1 | 0 | TCA metabolic process | GO:0072350 |
| 67 | TXNRD2 | Thioredoxin reductase 2 | 1 | 0 | response to oxygen radical | GO:0000305 |
| 68 | UQCRB | Cytochrome b-c1 complex subunit 7 | 1 | 0 | ATP metabolic process | GO:0046034 |
| 69 | UQCRC1 | Cytochrome b-c1 complex subunit 1 | 1 | 0 | ATP metabolic process | GO:0046034 |
| 70 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 5 | 0 | anion channel activity | GO:0005253 |
| 71 | VDAC3 | Voltage-dependent anion-selective channel protein 3 | 1 | 0 | anion channel activity | GO:0005253 |
Figure 3Analysis of the mitochondrial complex I and II activity, and cardiac ATP level. The activities of complex I and III were compared in irradiated and control samples (A,B). The ATP levels were compared in irradiated and control samples (C). The error bars represent standard error of the mean (± SEM) (t-test; * p < 0.05; n = 4).
Figure 4Analysis of the mitochondrial oxidative stress response. The expression level of mitochondrial SOD2 (A) and the amount of lipid peroxidation (B) as a marker of oxidative stress was measured in irradiated and control samples. The error bars represent standard error of the mean (± SEM) (t-test; * p < 0.05; n = 4).
Figure 5Analysis of the mitochondrial NAD+, NADH and NAD+/NADH and Acetyl-CoA. The concentration of NAD+, NADH and NAD+/NADH (A) and Acetyl-CoA (B) was compared in samples from irradiated and control groups. The error bars represent standard error of the mean (± SEM) (t-test; * p < 0.05; n = 4).
Figure 6Analysis of the sirtuin proteinsactivity and expression. The activity of sirtuin proteins was measured in mitochondria fraction using pan-SIRT assay. The error bars represent standard error of the mean (± SEM) (t-test; * p < 0.05; n = 3) (A). Immunoblotting analysis of SIRT3, SIRT4, SIRT5 was performed in the mitochondrial lysates from each group (B, C). The columns represent the average ratios of relative protein expression in control and irradiated samples after background correction (t-test; * p < 0.05; n = 3) (C). The activity of SIRT1 was compared between irradiated and control samples (t-test; * p < 0.05; n = 4) (D). Immunoblotting analysis of SIRT1 was performed using whole heart lysate. The error bars represent standard error of the mean (t-test; * p < 0.05; n = 4) (E,F). The amount of the total protein was measured by Ponceau S staining for an accurate comparison between the groups. The error bars represent standard error of the mean (± SEM) (t-test; * p < 0.05; n = 3).
Figure 7Analysis of the senescence-associated proteins. Immunoblotting analysis of the senescence markers (p21 and p16) in whole heart lysate (A,B). The amount of the total protein was measured by Ponceau S staining for an accurate comparison between the groups. The error bars represent standard error of the mean (± SEM) (t-test; * p < 0.05; n = 3).
Figure 8Analysis of the cardiac PGC-1 and PPAR alpha protein expression. Immunoblot analysis of total PGC1, and acetylated form (inactive) in whole heart lysate is shown (A). The columns represent the average ratios of relative protein expression in control and irradiated samples. The error bars represent standard error of the mean (± SEM) (t-test; * p < 0.05; n = 3) (B). Immunoblot analysis of total and phospho-PPAR alpha (Ser12) in whole heart lysate samples is shown (C). The amount of the total protein was measured by Ponceau S staining for an accurate comparison between the groups. The columns represent the average ratios of relative protein expression in control and irradiated samples after background correction (D). The error bars represent standard error of the mean (± SEM) (t-test; * p < 0.05; n = 4).
Figure 9A proposed model for the role of SIRT/ PGC-1/ PPAR alpha network in regulation of radiation-induced cardiac injury. Irradiation impairs the mitochondrial complex I activity resulting in NAD+ homeostasis alteration. A change in the level of NAD+/NADH reduces the activity of SIRT3 and enhances the acetylation state of mitochondrial proteins. NAD+/NADH alteration also affects the SIRT1 activity and impairs the PGC-1/ PPAR alpha transcription complex via an increased level of acetylated (inactive) PGC-1. Deactivation of PGC-1/ PPAR alpha is associated with a low level of myocardial metabolism, elevated oxidative damage and accelerated senescence contributing to the radiation-induced cardiac injury.